Bentinger Magnus, Turunen Mikael, Zhang Xiao-Xue, Wan Yu-Jui Yvonne, Dallner Gustav
Department of Biochemistry and Biophysics, Stockholm University, 10391 Stockholm, Sweden.
J Mol Biol. 2003 Feb 21;326(3):795-803. doi: 10.1016/s0022-2836(02)01447-x.
The nuclear retinoid X receptor alpha (RXRalpha) is the heterodimer partner in several nuclear receptors, some of them regulating lipid biosynthesis. Since coenzyme Q (CoQ) levels are greatly modified in aging and a number of diseases, we have investigated the involvement of RXRalpha in the biosynthetic regulation of this lipid by using a hepatocyte-specific RXRalpha-deficient mouse strain (RXRalpha-def). In the receptor-deficient liver, the amount of CoQ decreased to half of the control, and it was demonstrated that this decrease was caused by a significantly lowered rate of biosynthesis. On the other hand, induction of CoQ was extensive in both control and RXRalpha-def liver using the peroxisomal inducer di(2-ethylhexyl)phthalate (DEHP). Since the RXRalpha deficiency was specific to liver, no change in CoQ content or biosynthesis was observed in kidney. The other mevalonate pathway lipids, cholesterol and dolichol, were unchanged in the RXRalpha-def liver. Upon treatment with DEHP, cholesterol decreased in the control but remained unchanged in the receptor-deficient mice. In control mice, cold exposure elevated CoQ levels by 60%, but this induction did not occur in the liver of RXRalpha-def mice. In contrast, PPARalpha-null mice, which lack induction upon treatment with peroxisomal inducers, respond to cold exposure and CoQ content is increased. The amount of cholesterol decreased in both control and RXRalpha-def liver upon cold treatment. The results demonstrate that RXRalpha is required for CoQ biosynthesis and for its induction upon cold treatment, but does not appear to be involved in the basic synthesis of cholesterol and dolichol. The receptor is not involved in the elevated CoQ biosynthesis during peroxisomal induction.
核视黄酸X受体α(RXRα)是几种核受体中的异源二聚体伙伴,其中一些核受体调节脂质生物合成。由于辅酶Q(CoQ)水平在衰老和许多疾病中会发生很大变化,我们使用肝细胞特异性RXRα缺陷小鼠品系(RXRα-def)研究了RXRα在这种脂质生物合成调节中的作用。在受体缺陷型肝脏中,CoQ的量降至对照的一半,并且证明这种减少是由生物合成速率显著降低引起的。另一方面,使用过氧化物酶体诱导剂邻苯二甲酸二(2-乙基己基)酯(DEHP),对照和RXRα-def肝脏中CoQ的诱导都很广泛。由于RXRα缺陷仅限于肝脏,在肾脏中未观察到CoQ含量或生物合成的变化。其他甲羟戊酸途径脂质,胆固醇和多萜醇,在RXRα-def肝脏中没有变化。用DEHP处理后,对照小鼠中的胆固醇降低,但在受体缺陷小鼠中保持不变。在对照小鼠中,冷暴露使CoQ水平升高60%,但这种诱导在RXRα-def小鼠的肝脏中未发生。相比之下,缺乏过氧化物酶体诱导剂诱导反应的PPARα基因敲除小鼠对冷暴露有反应,CoQ含量增加。冷处理后,对照和RXRα-def肝脏中的胆固醇量均降低。结果表明,RXRα是CoQ生物合成及其冷处理诱导所必需的,但似乎不参与胆固醇和多萜醇的基础合成。该受体不参与过氧化物酶体诱导期间CoQ生物合成的升高。